Prostate Cancer
Targeting the adaptive molecular landscape in castrate-resistant prostate cancer
TFRI’s Vancouver-based prostate cancer progression team is primed and ready to continue its world-class research on advanced, drug-resistant tumours after receiving a five-year renewal of Terry ...
Read More